|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- August 20, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advaxis Inc., of North Brunswick, N.J., entered a collaboration with investigators at City of Hope for development of a vaccine to treat certain forms of leukemia and lymphoma based upon the company's Listeria monocytogenes vaccine technology platform. Advaxis provided a vaccine directed against the tumor-associated antigen WT-1. Financial terms of the deal were not disclosed.
AntiCancer Inc., of San Diego, used a cancer-specific adenovirus to express the green fluorescent protein gene selectively in tumors in mouse models of disseminated cancer. With lighting and a filter apparatus, scientists were able to see all the cancer in the mice and were able to ...